Oracle Power (ORCP), the international natural resources project developer, announced that further positive metallurgical results have been returned from the three samples from its 100% owned Northern Zone Gold Project,
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce an update on its current work
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Atome, Clontarf, Cap-XX, Jersey, IMC, McColls,
Zak Mir takes a charting look at some of the most followed small caps on the London market. Today’s selection includes Arkle, Bezant, Conroy, DP Eurasia, Genedrive, Kropz, Neometals, Optibiotix,
The market recovered on Friday after rising tensions over Russia and Ukraine caused share prices on the FTSE 100 to drop dramatically on Thursday.
All eyes are on Okyo (OKYO) as the biotechnology company announced that the patent entitled “Methods and Systems for Designing and/or Characterizing Soluble Lipidated has been issued by the United
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce its audited results for the year
The FTSE is down 1.26% after a tumultuous week with Barclays and HSBC the unfortunate culprits. However, UK stocks are looking positive as the gains for energy corporations increase as
N4 Pharma Plc (AIM: N4P), provide details of its work plan following the encouraging data from its oncology research as announced on 13 December 2021. The company sounded very positive
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide details of its work plan following
With its shares rising sharply against a falling market, shareholders of Russian Nickel play Amur Minerals (AMC) have been able to hold their head high against a falling market.
